Accordingly, the previously demonstrated lack of TCR signaling in ALCL [50] might result from the decreased expression of miR-181a/miR-181a* in ALK+ ALCL and provide a mechanism to evade immune surveillance. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.